1. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis;Ye;Lancet Gastroenterol Hepatol,2020
2. Fatty liver and drugs: the two sides of the same coin;Miele;Eur Rev Med Pharmacol Sci,2017
3. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016
4. Chemotherapy-associated steatohepatitis;Meunier;Ann Hepatol,2020
5. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N Engl J Med,2018